{
    "N/R/U": null,
    "Applicant": "Adaptimmune LLC",
    "BLA Number": "125789",
    "Proprietary Name": "tecelra",
    "Proper Name": "afamitresgene autoleucel",
    "BLA Type": "351(a)",
    "Strength": "2.68 x 10^9 to 10 x 10^9 CELL/ML",
    "Dosage Form": "Suspension",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Bag",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "August 01, 2024",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2315",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": "August 01, 2024",
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": "August 01, 2036",
    "Orphan Exclusivity Exp. Date": "August 01, 2031",
    "drug": [
        {
            "name": "afamitresgene autoleucel",
            "drugbank_id": "https://go.drugbank.com/drugs/DB18592"
        }
    ]
}